Analysts think INO stock price could increase by 361%
Apr 03, 2025, 11:25 AM
15.36%
What does INO do
Inovio Pharmaceuticals, based in San Diego, develops DNA medicines targeting infectious diseases, cancer, and HPV-related conditions, with key candidates including INO-3107 for recurrent respiratory papillomatosis. The company employs 122 people and utilizes CELLECTRA devices for DNA delivery.
7 analysts think INO stock price will increase by 360.84%. The current median analyst target is $7.65 compared to a current stock price of $1.66. The lowest analysts target is $2.02 and the highest analyst target is $15.75.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.